158 related articles for article (PubMed ID: 33219317)
21. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
22. Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.
Wang N; Song L; Xu Y; Zhang L; Wu Y; Guo J; Ji W; Li L; Zhao J; Zhang X; Zhan L
EBioMedicine; 2019 Sep; 47():65-77. PubMed ID: 31495720
[TBL] [Abstract][Full Text] [Related]
23. Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines.
Skowron MA; Niegisch G; Albrecht P; van Koeveringe G; Romano A; Albers P; Schulz WA; Hoffmann MJ
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767070
[TBL] [Abstract][Full Text] [Related]
24. Induction of ferroptosis by ATF3 elevation alleviates cisplatin resistance in gastric cancer by restraining Nrf2/Keap1/xCT signaling.
Fu D; Wang C; Yu L; Yu R
Cell Mol Biol Lett; 2021 Jun; 26(1):26. PubMed ID: 34098867
[TBL] [Abstract][Full Text] [Related]
25. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
26. Ufbp1, a Key Player of Ufm1 Conjugation System, Protects Against Ketosis-Induced Liver Injury via Suppressing Smad3 Activation.
Chen F; Sheng L; Xu C; Li J; Ali I; Li H; Cai Y
Front Cell Dev Biol; 2021; 9():676789. PubMed ID: 34307359
[TBL] [Abstract][Full Text] [Related]
27. Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway.
Kageyama S; Sou YS; Uemura T; Kametaka S; Saito T; Ishimura R; Kouno T; Bedford L; Mayer RJ; Lee MS; Yamamoto M; Waguri S; Tanaka K; Komatsu M
J Biol Chem; 2014 Sep; 289(36):24944-55. PubMed ID: 25049227
[TBL] [Abstract][Full Text] [Related]
28. DJ-1 is involved in the multidrug resistance of SGC7901 gastric cancer cells through PTEN/PI3K/Akt/Nrf2 pathway.
Qiu L; Ma Z; Li X; Deng Y; Duan G; Zhao LE; Xu X; Xiao L; Liu H; Zhu Z; Chen H
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(11):1202-1214. PubMed ID: 33079995
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
Villeneuve NF; Lau A; Zhang DD
Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
[TBL] [Abstract][Full Text] [Related]
30. Acetyl-l-carnitine prevents homocysteine-induced suppression of Nrf2/Keap1 mediated antioxidation in human lens epithelial cells.
Yang SP; Yang XZ; Cao GP
Mol Med Rep; 2015 Jul; 12(1):1145-50. PubMed ID: 25776802
[TBL] [Abstract][Full Text] [Related]
31. FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation.
Zou S; Ma C; Yang F; Xu X; Jia J; Liu Z
Mol Cancer Res; 2018 Feb; 16(2):286-295. PubMed ID: 29117943
[TBL] [Abstract][Full Text] [Related]
32. A non-canonical scaffold-type E3 ligase complex mediates protein UFMylation.
Peter JJ; Magnussen HM; DaRosa PA; Millrine D; Matthews SP; Lamoliatte F; Sundaramoorthy R; Kopito RR; Kulathu Y
EMBO J; 2022 Nov; 41(21):e111015. PubMed ID: 36121123
[TBL] [Abstract][Full Text] [Related]
33. Concerted action of p62 and Nrf2 protects cells from palmitic acid-induced lipotoxicity.
Park JS; Kang DH; Lee DH; Bae SH
Biochem Biophys Res Commun; 2015 Oct; 466(1):131-7. PubMed ID: 26325428
[TBL] [Abstract][Full Text] [Related]
34. KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response.
Sun Z; Wu T; Zhao F; Lau A; Birch CM; Zhang DD
Mol Cell Biol; 2011 May; 31(9):1800-11. PubMed ID: 21383067
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological stimulation of nuclear factor (erythroid-derived 2)-like 2 translation activates antioxidant responses.
Perez-Leal O; Barrero CA; Merali S
J Biol Chem; 2017 Aug; 292(34):14108-14121. PubMed ID: 28684421
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease.
Tebay LE; Robertson H; Durant ST; Vitale SR; Penning TM; Dinkova-Kostova AT; Hayes JD
Free Radic Biol Med; 2015 Nov; 88(Pt B):108-146. PubMed ID: 26122708
[TBL] [Abstract][Full Text] [Related]
37. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
[TBL] [Abstract][Full Text] [Related]
38. NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitination-proteasomal degradation, and transcription activation.
He X; Ma Q
Mol Pharmacol; 2009 Dec; 76(6):1265-78. PubMed ID: 19786557
[TBL] [Abstract][Full Text] [Related]
39. GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma.
Hayashi M; Guida E; Inokawa Y; Goldberg R; Reis LO; Ooki A; Pilli M; Sadhukhan P; Woo J; Choi W; Izumchenko E; Gonzalez LM; Marchionni L; Zhavoronkov A; Brait M; Bivalacqua T; Baras A; Netto GJ; Koch W; Singh A; Hoque MO
Sci Signal; 2020 Aug; 13(645):. PubMed ID: 32817372
[TBL] [Abstract][Full Text] [Related]
40. Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.
Wang XJ; Li Y; Luo L; Wang H; Chi Z; Xin A; Li X; Wu J; Tang X
Free Radic Biol Med; 2014 May; 70():68-77. PubMed ID: 24556415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
